1. High Incidence of EGFR Mutations in Pneumonic-Type Non-Small Cell Lung Cancer
   Jun Liu et al, 2015, Medicine CrossRef
2. Improved detection of EGFR mutations in the tumor cells enriched from the malignant pleural effusion of non-small cell lung cancer patient
   Yi Wang et al, 2018, Gene CrossRef
3. Gene expression of MAGE‐A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non–small cell lung cancer patients
   Szu‐Hua Pan et al, 2017, Asia-Pacific Journal of Clinical Oncology CrossRef
4. Real‐world data on EGFR/ALK gene status and first‐line targeted therapy rate in newly diagnosed advanced non‐small cell lung cancer patients in Northern China: A prospective observational study
   Hongge Liang et al, 2019, Thoracic Cancer CrossRef
5. Apatinib inhibits cellular invasion and migration by fusion kinase KIF5B-RET via suppressing RET/Src signaling pathway
   Chen Lin et al, 2016, Oncotarget CrossRef
6. EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study
   Baohui Han et al, 2017, Lung Cancer CrossRef
7. Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis
   Yongfeng Wu et al, 2021, Pathology - Research and Practice CrossRef
8. The RET fusion gene and its correlation with demographic and clinicopathological features of non-small cell lung cancer: a meta-analysis
   Chen Lin et al, 2015, Cancer Biology & Therapy CrossRef